↓ Skip to main content

Dove Medical Press

Avasimibe inhibits tumor growth by targeting FoxM1-AKR1C1 in osteosarcoma

Overview of attention for article published in OncoTargets and therapy, January 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter
4 X users
facebook
2 Facebook pages

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
7 Mendeley
Title
Avasimibe inhibits tumor growth by targeting FoxM1-AKR1C1 in osteosarcoma
Published in
OncoTargets and therapy, January 2019
DOI 10.2147/ott.s165647
Pubmed ID
Authors

Liang Wang, Yang Liu, Guanzhen Yu

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 7 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 7 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 3 43%
Student > Bachelor 2 29%
Professor > Associate Professor 1 14%
Unknown 1 14%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 3 43%
Arts and Humanities 1 14%
Agricultural and Biological Sciences 1 14%
Medicine and Dentistry 1 14%
Unknown 1 14%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 January 2019.
All research outputs
#14,829,318
of 25,728,855 outputs
Outputs from OncoTargets and therapy
#735
of 3,013 outputs
Outputs of similar age
#223,663
of 449,068 outputs
Outputs of similar age from OncoTargets and therapy
#20
of 100 outputs
Altmetric has tracked 25,728,855 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,013 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 449,068 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 100 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.